Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
Jason K. Sicklick(University of California San Diego), Anna Mae Diehl(Duke Medical Center), Rajesh Kannangai(Johns Hopkins University), Aruna Jayaraman(Johns Hopkins University), Yi Qi(Princeton University), Wei Chen(Jiangnan University), Perumal Vivekanandan(Indian Institute of Technology Delhi), Yin-xiong Li(Duke Medical Center), Michael Torbenson(Mayo Clinic), John W. Ludlow(Memorial Sloan Kettering Cancer Center), Kouros Owzar(Duke University)
Cited by 267
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k